AstraZeneca PLC

Stock Chart, Company Information, and Scan Results

$182.52(as of May 7, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

AstraZeneca PLC Company Information, Fundamentals, and Technical Indicators

Stock Price$182.52
Ticker SymbolAZN
ExchangeNasdaq
SectorHealthcare
IndustryDrug Manufacturers - General
Employees96,100
CountyUSA
Market Cap$286,678.4M
EBIDTA19,994.0M
10-Day Moving Average185.34
P/E Ratio27.42
20-Day Moving Average192.71
Forward P/E Ratio17.83
50-Day Moving Average194.24
Earnings per Share6.64
200-Day Moving Average176.80
Profit Margin20.15%
RSI36.27
Shares Outstanding1,550.3M
ATR3.97
52-Week High210.50
Volume1,281,194
52-Week Low130.04
Most Recent Support Level180.00
Book Value47,384.0M
Most Recent Resistance Level185.61
P/B Ratio6.01
Upper Keltner201.63
P/S Ratio4.71
Lower Keltner183.78
Debt-to-Equity Ratio201.63
Next Earnings DateUnknown
Cash Surplus-25,010.0M
Next Ex-Dividend DateUnknown

AstraZeneca is a Swedish-based pharmaceutical giant dedicated to discovering and developing innovative treatments for conditions like cancer and respiratory diseases. The company gained popularity during the novel COVID-19 pandemic with the development of viral vector vaccines to treat the virus. The company’s most popular product is Tagrisso—a medication used to treat lung carcinomas.

AstraZeneca PLC In Our Stock Scanner

As of May 07, 2026
As of ---
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.